-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Versigent, Raises Price Target to $49

Benzinga·05/06/2026 19:51:15
Listen to the news
TD Cowen analyst Itay Michaeli maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $47 to $49.